January 1, 2022Open Access

Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

In postmenopausal women with osteoporosis, DEN was associated with greater BMD increase at all measured skeletal sites, greater increase of TBS, and greater inhibition of bone remodeling compared with ZOL.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Kang et al. (Sat,) studied this question.

synapsesocial.com/papers/69d94d1dc7f0c3ae80a3cb68 https://doi.org/https://doi.org/10.3346/jkms.2022.37.e68

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis2017 · 43 citations
2A review of magnetic resonance (MR) imaging of trabecular bone micro-architecture: contribution to the prediction of biomechanical properties and fracture prevalence1998 · 63 citations
3NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: Highlights of the Conference*2001 · 217 citations
4Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States2017 · 91 citations
5Three-Dimensional (3D) Microarchitecture Correlations with 2D Projection Image Gray-Level Variations Assessed by Trabecular Bone Score Using High-Resolution Computed Tomographic Acquisitions: Effects of Resolution and Noise2012 · 200 citations

Me gusta

Guardar

Ver artículo completo